Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community
Oncology Research Program (NCORP)
Target: n/a Total: 2374
SPECIMEN COLLECTION AUGUSTA UNIVERSITY
Early Onset Malignancies Initiative (EOMI): Molecular profiling of Breast, Prostate,
Colorectal, Liver, Kidney, and Multiple Myeloma among Racially and Ethnically Diverse
Populations
AUGUSTA UNIVERSITY
Patient-derived Models Tissue Procurement Protocol for the National Cancer Institute
Screening Target: 6452 Screening Total: 6507
Intervention Target: 1425 Intervention Total: 778
AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
Target: 317 Total: 221
AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
Target: 1475 Total: 1113
AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
ATHENS & DEKALB MEDICAL
AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
ATHENS & DEKALB MEDICAL
ATHENS & DEKALB MEDICAL
ATHENS, DEKALB MEDICAL & PHOEBE CANCER CENTER
AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
AUGUSTA UNIVERSITY, ATHENS, DEKALB MEDICAL & PHOEBE CANCER CENTER
AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
Target: 1000 Total: 171
AUGUSTA UNIVERSITY
Target: 210 Total: 132
AUGUSTA UNIVERSITY
Target: 128 Total: 49
AUGUSTA UNIVERSITY
Target: 52 Total: 36
AUGUSTA UNIVERSITY & DEKALB MEDICAL
Target: 285 Total: 171
AUGUSTA UNIVERSITY
Target: 188 Total: 97
AUGUSTA UNIVERSITY
Target: 147 Total: 17
AUGUSTA UNIVERSITY & DEKALB MEDICAL
Target: 488 Total: 32
AUGUSTA UNIVERSITY, DEKALB MEDICAL & MOOREHOUSE
Target: 1150 Total: 1129
AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
Target: 612 Total: 179
ATHENS
Target: 576 Total: 310
ATHENS
Target: 130 Total: 14
AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
Target: 200 Total: 25
Temporarily Closed to Accrual
Cohort 1 Closed
AUGUSTA UNIVERSITY
Target: 302 Total: 24
AUGUSTA UNIVERSITY
Target: 689 Total: 17
Target: 8300 Total: 3046
Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients
with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small
Cell Lung Cancer (NSCLC)
Target: 450 Total: 194
A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell
Lung Cancer: Crizotinib Versus Placebo for Patients with Tumors Harboring the Anaplastic
Lymphoma Kinase (ALK) Fusion Protein
Target: 378 Total: 61
Target: 714 Total: 338
AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
Target: 300 Total: 140
AUGUSTA UNIVERSITY, ATHENS & DEKALB MEDICAL
Temporarily Closed
Target: 400 Total: 250
AUGUSTA UNIVERSITY
Target: 172 Total: 48
AUGUSTA UNIVERSITY
Target: 3960 Total: 1632
Target: 17230 Total: 16078
Target: 5872 Total: 8906
Temporarily Closed
Target: 5437 Total: 5031
Temporarily Closed
Target: 1400 Total: 832
Target: 400 Total: 399
Target: 330 Total: 189
Target: 8100 Total: 3482
Target: 621 Total: 198
Neuroblastoma Biology Studies
Target: 10,000 Total: 9869
Total: 5987
Target: 340 Total: 115
